China Jo-Jo Drugstores Holdings

China Jo-Jo Drugstores, Inc. operates as an online and offline retailer and wholesale distributor of pharmaceutical and other healthcare products. It also operates an online pharmacy and retail drugstores with licensed doctors on site for consultation, examination, and treatment of common ailments at scheduled hours. Its business segments include retail drugstores, an online pharmacy, wholesale distribution of products similar to those carried in its pharmacies, and the cultivation and sale of herbs used for traditional Chinese medicine. The company was founded in September 2003 and is headquartered in Hangzhou, China.

Earnings data Q3 2020

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

China Jo-Jo Drugstores, Inc. engages in retailing and distributing pharmaceutical and other healthcare products. It operates through the following business segments: Retail Drugstores, Online Pharmacy, Drug Wholesale, and Herb Farming. The Retail Drugstores segment refers to the selling of prescription and over-the-counter medicines, dietary supplements, medical devices, and sundry items to retail customers. The Online Pharmacy segment is involved in selling of over-the-counter drugs, dietary supplements, medical devices, and sundry items through several third-party platforms. The Drug Wholesale segment includes supplying its retail drugstores with prescription and over-the-counter medicines, and selling its products to other drug vendors and hospitals. The Herb Farming cultivates selected herbs for sales to other drug vendors. The company was founded by Li Qi in September 2003 and is headquartered in Hangzhou, China.

HANGZHOU, China , July 30, 2024 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced its financial results for the fiscal year ended March 31, 2024. Mr. Lei Liu, Chairman and CEO of Jo-Jo Drugstores, commented, "We are pleased to present our financial performance for fiscal year 2024, which reflects our commitment to maintaining a resilient business model in a dynamic market.

China Jo-Jo Drugstores Reports Fiscal Year 2024 Financial Results

HANGZHOU, China , June 11, 2024 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that it has entered into definitive agreements with a number of investors providing for the issuance of 1,980,000 million ordinary shares, at a purchase price of $1.70 per share, in a registered direct offering for an aggregate gross proceeds of approximately $3.37 million. The closing of the sale of the securities is expected to occur on or about June 26, 2024, subject to satisfaction of customary closing conditions.

China Jo-Jo Drugstores Announces $3.37 Million Registered Direct Offering

HANGZHOU, China , May 31, 2024 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that Ms. Pingfan Wu has resigned from her position as a member of the board of directors (the "Board") due to personal reasons, effective on May 31, 2024.

China Jo-Jo Drugstores Announces Changes to Board of Directors

HANGZHOU, China , May 10, 2024 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that it has entered into definitive agreements with a number of investors providing for the issuance of 1.61 million ordinary shares, at a purchase price of $1.70 per share, in a registered direct offering for aggregate gross proceeds of approximately $2.74 million. The closing of the sale of the securities is expected to occur on or about May 17, 2024, subject to satisfaction of customary closing conditions.

China Jo-Jo Drugstores Announces $2.74 Million Registered Direct Offering

HANGZHOU, China , April 29, 2024 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that it has entered into definitive agreements with a number of investors providing for the issuance of 0.9 million ordinary shares, at a purchase price of $1.70 per share, in a registered direct offering for aggregate gross proceeds of approximately $1.53 million. The closing of the sale of the securities is expected to occur on or about April 30, 2024, subject to satisfaction of customary closing conditions.

China Jo-Jo Drugstores Announces $1.53 Million Registered Direct Offering

HANGZHOU, China , March 19, 2024 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that it received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") on March 15, 2024, notifying the Company that it has regained compliance with the Nasdaq Capital Market's minimum bid price requirement and the matter is closed. On June 15, 2023, the Company was first notified by Nasdaq its failure to maintain a minimum bid price of $1.00 per share for 30 consecutive trading days under Nasdaq Listing Rules 5550(a)(2) and 5810(c)(3)(A), and was given its first 180-day extension, or until December 12, 2023 to regain compliance.

China Jo-Jo Drugstores Regains Compliance with Nasdaq Minimum Bid Price Requirement

HANGZHOU, China , Feb. 27, 2024 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (the "Company") (Nasdaq: CJJD), a Cayman Islands exempted company, reported that it expects to implement a 1-for-20 reverse stock split on its ordinary shares ("Ordinary Shares") effective Friday, March 1, 2024, with trading to begin on a split-adjusted basis at the market open on that day. Trading in the Ordinary Shares will continue on the Nasdaq Capital Market under the symbol "CJJD".

China Jo-Jo Drugstores, Inc. Announces 1-for-20 Reverse Stock Split

HANGZHOU, China , Dec. 14, 2023 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) (the "Company"), a leading online and offline retailer and wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that on December 13, 2023, the Company received another 180 calendar day extension from Nasdaq's Listing Qualifications Department ("Nasdaq") to meet Nasdaq's continuing listing requirements by maintaining a minimum bid price per share of $1.00 for a minimum of 10 consecutive trading days (the "Minimum Bid Price Rules"). The Company now has until June 10, 2024 to regain compliance with the Minimum Bid Price Rules.

China Jo-Jo Drugstores Granted A Second Extension to Meet Nasdaq Minimum Bid Price Requirement

HANGZHOU, China , Nov. 8, 2023 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that its 20th Anniversary Ceremony (the "Ceremony") was held in Hangzhou. The Ceremony not only marks a milestone in the Company's history, but also heralds a new chapter for its future growth.

China Jo-Jo Drugstores Announces Celebration of its 20th Anniversary

HANGZHOU, China, Sept. 26, 2023 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that it has entered into definitive agreements with a number of investors providing for the issuance of 9.96 million ordinary shares, at a purchase price of $0.26 per share (the "Purchase Price"), in a registered direct offering for aggregate gross proceeds of approximately $2.59 million.

China Jo-Jo Drugstores Announces $2.59 Million Registered Direct Offering

HANGZHOU, China , June 16, 2023 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that on June 15, 2023, the Company has received a notification letter from Nasdaq Listing Qualifications Department ("Nasdaq") notifying the Company that it is not in compliance with the minimum bid price requirement from May 3, 2023 through June 14, 2023. As set forth in Nasdaq Listing Rules 5550(a)(2) ("Nasdaq Listing Rule"), it requires that the closing bid price for the Company's ordinary shares listed on Nasdaq be maintained at a minimum of US$1.00 and failure to meet it for 30 consecutive trading days constitutes a compliance deficiency.

China Jo-Jo Drugstores Announced Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

HANGZHOU, China , June 15, 2023 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced its financial results for the fiscal year ended March 31, 2023. Mr. Lei Liu, Chairman and CEO of Jo-Jo Drugstores, commented, "During the past fiscal year, we continued to provide high-quality services and products to our customers despite the challenging and uncertain market environment.

China Jo-Jo Drugstores Reports Fiscal Year 2023 Financial Results

Addentax Group Corp

Baosheng Media Group Holdings

GD Culture Group Limited

AMTD Digital

Huadi International Group

JX Luxventure Ltd

Leju Holdings Ltd.

Magic Empire Global Ltd

Mmtec Inc

Powerbridge Technologies Co Ltd

Quhuo Limited

Sentage Holdings

Tian Ruixiang Holdings

Zhong Yang Financial Group Ltd

Wah Fu Education Group Ltd

WeTrade Group Inc

Small-cap Chinese stocks have been attracting plenty of attention in recent days, according to data from Stocktwits, a social platform for investors and traders.

Small-cap Chinese stocks spark meme-like buzz

HANGZHOU, China , May 2, 2023 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that the Company had received the Hangzhou Municipal People's Government Quality Management Excellence Award (the "Award"), the most prestigious quality recognition established by Hangzhou Municipal People's Government and reviewed by the Market Supervision and Administration Bureau of Hangzhou City. Established in 2010, the Award is designed to recognize enterprises or organizations that have implemented exceptional performance management and created notable economic and social benefits in areas such as production, construction, services, and environmental protection.

China Jo-Jo Drugstores Receives Hangzhou Municipal People's Government Quality Management Excellence Award

Farmer Bros.

Mangoceuticals Inc

Vital Farms, Inc.

The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.

Top 4 Risk Off Stocks That Are Preparing To Pump This Month

China Jo-Jo Drugstores (NASDAQ: CJJD) stock price has cratered as the future of the company remains in peril. The shares plunged to a low of $0.67, the lowest level in months.

China Jo-Jo Drugstores stock: Avoid this dilution machine

Bed Bath & Beyond

BIOLASE

How to evaluate penny stocks using risk management techniques The post Penny Stock Risk Assessment: Evaluating Potential Investments  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Penny Stock Risk Assessment: Evaluating Potential Investments

On another mixed session today, investors appear to be humming and hawing about how many large-cap stocks will perform. However, there's outsized interest in some small-cap names today, with China Jo-Jo Drugstores (NASDAQ: CJJD ) seeing impressive buying pressure.

3 Investors Betting Big on China Jo-Jo Drugstores (CJJD) Stock

HANGZHOU, China , April 19, 2023 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, announced today that the previously announced registered direct offering to issue 2,258,888 ordinary shares and registered warrants to purchase up to 4,517,776 ordinary shares to an institutional investor was terminated. No securities were sold pursuant to the Company's shelf registration statement on Form F-3 (No.

China Jo-Jo Drugstores Announces the Termination of the Previously Proposed Registered Direct Offering

HANGZHOU, China, April 18, 2023 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that it has entered into a definitive agreement with an institutional investor (the "Investor") providing for the issuance of 2,258,888 ordinary shares, at a purchase price of $3.10 per share, in a registered direct offering for aggregate gross proceeds of approximately $7 million.

China Jo-Jo Drugstores Announces $7 Million Registered Direct Offering

HANGZHOU, China , Jan. 20, 2023 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that it has entered into definitive agreements with a number of investors providing for the issuance of 1.75 million ordinary shares, at a purchase price of $1.50 per share, in a registered direct offering for aggregate gross proceeds of $2.625 million. Jo-Jo Drugstores also agreed to issue to the investors registered warrants to purchase up to 5.25 million ordinary shares.

China Jo-Jo Drugstores Announces $2.625 Million Registered Direct Offering

U.S.-listed shares of China Jo-Jo Drugstores Inc. CJJD, +9.40% were up about 21% in premarket trading on Friday. The company, which is based in Hangzhou, China, operates drugstores and an online pharmacy in China.

China Jo-Jo Drugstores shares rally

HANGZHOU, China , July 28, 2022 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced its financial results for the fiscal year ended March 31, 2022. Mr. Lei Liu, Chairman and CEO of Jo-Jo Drugstores, commented, "We are pleased with our fiscal year 2022 financial results, which reflect our continued growth momentum that we have achieved overall improvement across all key financial metrics.

China Jo-Jo Drugstores Reports Fiscal Year 2022 Financial Results

E-Home Household Service Holdings Ltd

Toughbuilt Industries Inc

Visionary Education Technology Holdings Group Inc

Low float penny stocks to watch this week. The post 4 Low Float Penny Stocks To Watch This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

4 Low Float Penny Stocks To Watch This Week

HANGZHOU, China, April 6, 2022 /PRNewswire/ – China Jo-Jo Drugstores, Inc. ("Jo-Jo Drugstores" or the "Company") (Nasdaq: CJJD), a Cayman Islands company, reported that it expects to implement a 1-for-12 reverse stock split on its ordinary shares effective Thursday, April 7, 2022, with trading to begin on a split-adjusted basis at the market open on that day. Trading in the ordinary shares will continue on the Nasdaq Capital Market under the symbol "CJJD".

News for China Jo-Jo Drugstores Holdings Stock (CJJD)